Julie Rubinstein

Title: Innovations and Contributions of Julie Rubinstein

Introduction

Julie Rubinstein is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of immunology. With a total of three patents to her name, she has made remarkable strides in understanding the adaptive immune system. Her work focuses on assessing immunocompetence, which is crucial for developing effective immunotherapies.

Latest Patents

One of her latest patents is titled "Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization." This patent discloses methods for determining the immunological status of the adaptive immune system by identifying and quantifying rearranged DNA and/or transcribed RNA sequences that encode T cell receptor (TCR) and immunoglobulin (IG) polypeptides. The methods allow for the assessment of immunocompetence and immune repertoire, reflecting the degree of T cell or B cell clonality and clonal expansion in a lymphoid DNA-containing sample. Additionally, the patent describes methods for stratifying patient populations based on immunocompetence, including the likelihood of responding to immunotherapy.

Career Highlights

Julie has worked with notable organizations such as Adaptive Biotechnologies Corporation and Memorial Sloan Kettering Cancer Center. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Harlan Saul Robins and Ryan O Emerson. Their collaborative efforts have further advanced the understanding of immunological responses and the development of innovative therapies.

Conclusion

Julie Rubinstein's work exemplifies the intersection of innovation and healthcare, particularly in the realm of immunology. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.